Table 1.
Clinical characteristics according to adiponectin quartiles
| Characteristics | Q1 | Q2 | Q3 | Q4 | P |
|---|---|---|---|---|---|
| Age | 60.6 ± 9.4 | 60.7 ± 9.6 | 64.3 ± 11.2 | 64.9 ± 11.8 | 0.29 |
| Female sex | 25% | 31% | 51.7% | 57.1% | 0.037 |
| Caucasian ethnicity | 71.4% | 86.2% | 89.7% | 85.7% | 0.84 |
| Δt for admission, min | 353 ± 45 | 412 ± 62 | 482 ± 101 | 330 ± 65 | 0.47 |
| Weight, kg | 81.8 ± 14.5 | 77.2 ± 12.8 | 70.5 ± 13.2 | 66 ± 13.5 | 0.0001 |
| BMI, kg/m2 | 29.6 ± 5.2 | 28.3 ± 5.0 | 27.5 ± 4.4 | 26.4 ± 5.3 | 0.10 |
| Waist circumference, cm | 105.2 ± 11.8 | 99.2 ± 12.8 | 97.1 ± 11.4 | 93.4 ± 12.0 | 0.004 |
| SBP, mmHg | 136 ± 22.6 | 137 ± 33 | 147 ± 22.6 | 142 ± 30.4 | 0.38 |
| DBP, mmHg | 81 ± 18.2 | 81 ± 17.3 | 84 ± 13.1 | 85 ± 16.9 | 0.72 |
| HR, bpm | 73 ± 12 | 76 ± 16 | 76 ± 15 | 83 ± 23 | 0.61 |
| Killip I | 96.3% | 89.3% | 85.2% | 89.3% | 0.52 |
| Killip II/III | 3.7% | 3.6% | 11.1% | 10.7% | |
| Killip IV | 0% | 7.1% | 3.7% | 0% | |
| Diabetes mellitus | 35.7% | 24.1% | 31% | 28.6% | 0.81 |
| Dyslipidemia | 85.7% | 72.4% | 82.8% | 71.4% | 0.48 |
| Previous AMI | 60.7% | 44.8% | 44.8% | 39.3% | 0.41 |
| Previous PCI | 46.4% | 37.9% | 48.3% | 42.9% | 0.88 |
| Previous CABG | 28.6% | 25% | 27.6% | 17.9% | 0.82 |
| Previous stroke | 10.7% | 3.4% | 10.7% | 3.7% | 0.59 |
| Current smoking | 10.7% | 13.8% | 23.1% | 18.5% | 0.62 |
| Previous angina | 57.1% | 58.6% | 58.6% | 46.4% | 0.77 |
| Previous CKF | 7.1% | 0% | 6.9% | 14.3% | 0.24 |
| SAH | 92.9% | 82.8% | 96.6% | 85.7% | 0.30 |
| LVEF | 0.53 | 0.49 | 0.53 | 0.46 | 0.66 |
| Moderate/severe LV dysfunction | 33.3% | 42.3% | 19.2% | 30.4% | 0.35 |
∆t: time interval; HR: heart rate; LVEF: left ventricular ejection fraction; SAH: systemic arterial hypertension; BMI: body mass index; CKF: chronic kidney failure; DBP: diastolic blood pressure; SBP: systolic blood pressure; CABG: coronary artery bypass graft surgery; LV: left ventricle.